Literature DB >> 16725125

Repeated l-DOPA treatment increases c-fos and BDNF mRNAs in the subthalamic nucleus in the 6-OHDA rat model of Parkinson's disease.

Xiaoqun Zhang1, Per E Andren, Per Svenningsson.   

Abstract

The subthalamic nucleus and the striatum are input regions of the basal ganglia. This study used the unilateral 6-OHDA rat model of Parkinson's disease to examine effects of l-DOPA on the expression of c-fos and BDNF mRNAs in these nuclei. Dopamine depletion per se did not affect c-fos or BDNF. Both a single and repeated injections of l-DOPA induced c-fos, but not BDNF, in the dopamine-depleted striatum. However, repeated l-DOPA treatment increased c-fos and BDNF in the dopamine-depleted subthalamic nucleus. These molecular adaptations may reflect changes in neuronal plasticity that underlie some therapeutic actions and/or side effects of l-DOPA in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16725125     DOI: 10.1016/j.brainres.2006.04.019

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

Review 1.  Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?

Authors:  Paolo Calabresi; Veronica Ghiglieri; Petra Mazzocchetti; Ilenia Corbelli; Barbara Picconi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

Review 2.  Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.

Authors:  Tiago Martins Rodrigues; André Jerónimo-Santos; Tiago Fleming Outeiro; Ana Maria Sebastião; Maria José Diógenes
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

3.  Subthalamic Nucleus Deep Brain Stimulation Employs trkB Signaling for Neuroprotection and Functional Restoration.

Authors:  D Luke Fischer; Christopher J Kemp; Allyson Cole-Strauss; Nicole K Polinski; Katrina L Paumier; Jack W Lipton; Kathy Steece-Collier; Timothy J Collier; Daniel J Buhlinger; Caryl E Sortwell
Journal:  J Neurosci       Date:  2017-06-12       Impact factor: 6.167

4.  Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3beta phosphorylation.

Authors:  Zhongshu Tang; Pachiappan Arjunan; Chunsik Lee; Yang Li; Anil Kumar; Xu Hou; Bin Wang; Piotr Wardega; Fan Zhang; Lijin Dong; Yongqing Zhang; Shi-Zhuang Zhang; Hao Ding; Robert N Fariss; Kevin G Becker; Johan Lennartsson; Nobuo Nagai; Yihai Cao; Xuri Li
Journal:  J Exp Med       Date:  2010-03-15       Impact factor: 14.307

5.  Serum brain-derived neurotrophic factor levels in different neurological diseases.

Authors:  Mariacarla Ventriglia; Roberta Zanardini; Cristina Bonomini; Orazio Zanetti; Daniele Volpe; Patrizio Pasqualetti; Massimo Gennarelli; Luisella Bocchio-Chiavetto
Journal:  Biomed Res Int       Date:  2013-08-19       Impact factor: 3.411

6.  Serum concentration and clinical significance of brain-derived neurotrophic factor in patients with Parkinson's disease or essential tremor.

Authors:  Yixian Huang; Wenwei Yun; Min Zhang; Weifeng Luo; Xianju Zhou
Journal:  J Int Med Res       Date:  2018-01-19       Impact factor: 1.671

7.  BDNF provides many routes toward STN DBS-mediated disease modification.

Authors:  D Luke Fischer; Caryl E Sortwell
Journal:  Mov Disord       Date:  2018-11-15       Impact factor: 10.338

Review 8.  l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson's Disease.

Authors:  Yoshio Goshima; Daiki Masukawa; Yuka Kasahara; Tatsuo Hashimoto; Aderemi Caleb Aladeokin
Journal:  Front Pharmacol       Date:  2019-10-03       Impact factor: 5.810

9.  High-Frequency Stimulation of the Rat Entopeduncular Nucleus Does Not Provide Functional or Morphological Neuroprotection from 6-Hydroxydopamine.

Authors:  D Luke Fischer; Timothy J Collier; Allyson Cole-Strauss; Susan L Wohlgenant; Jack W Lipton; Kathy Steece-Collier; Fredric P Manfredsson; Christopher J Kemp; Caryl E Sortwell
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

Review 10.  Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson's Disease.

Authors:  Wook Jin
Journal:  J Clin Med       Date:  2020-01-17       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.